Professional Documents
Culture Documents
(BIOCHEM) 6.02 Gene Expression II-Transcription (Dr. Magat) PDF
(BIOCHEM) 6.02 Gene Expression II-Transcription (Dr. Magat) PDF
02
OUTLINE
I. Overview of transcription
A. Definition of terms
B. Structure of RNA polymerase
C. Types of RNA polymerase
D. Structure of Prokaryotic and Eukatyotic mRNA
E. Compare and contrast Transcription and
Replication
II. Initiation (mRNA)
A. mRNA Promoter Regions
B. Initiation Complex Assembly
C. General Transcription Factors (GTF)
D. Gene Specific Transcription factors (GSTF)
E. Steps of initiation
F. Role of CTD in Transcription
G. Clinical Correlation: Xeroderma Pigmentosum
H. DNA Binding Domain and Mediator Proteins
III. Elongation mRNA
IV. Transcriptional modification
A. Co-transcriptional Modification
B. Post-transcriptional Modification
V. rRNA synthesis
A. Initiation
B. Post transcriptional Modification
C. Formation of Base modification Figure 1. Flowchart illustrating how genetic information encoded in DNA
VI. tRNA Synthesis produces proteins
A. Initiation
B. Posttranscriptional Modification DNA codes have to be transcribed (copied) into RNA (mRNA,
C. Formation of Structure rRNA, & tRNA) first before they can be translated (produced)
D. Base Modification into proteins as the final gene products.
VII. Export to Cytoplasm
VIII. Decay of Normal Eukaryotic RNA Transcription
A. Co-transcriptional Modification The synthesis of RNA whose sequence is complementary to
B. Post-transcriptional Modification that of a DNAs template. Transcription begins at a promoter
IX. Regulation sequence and proceeds in the 5’ to 3’ direction. (Devlin)
A. Epigenetics: Chromatin Remodeling Transcription is a complex process dependent on a major
B. Regulation of HMG CoA Reductase polymerase enzyme and a cast of supporting proteins.
X. Clinical Correlation: Metformin Involves the Watson-Crick base pairing between
nucleotides of the template strand
LEARNING OBJECTIVES Initial process of RNA synthesis
Unique to transcription: There is co-transcriptional and
At the end of the lecture, the student should be able to: post-transcriptional modifications/processing of the
To Compare and contrast: replication & transcription; primary transcript
prokaryotic & eukaryotic transcription; types of RNAP o Co-transcriptional modification – process of
To Summarize: steps in eukaryotic RNA synthesis, co- and covalently altering the RNA sequence after the
post - transcriptional modifications, export to cytoplasm, and transcription begun but before the RNA has
decay been released from the RNA polymerase; while
Conclude how regulatory (including epigenetic) mechanisms at transcription is occurring, the primary transcript
the transcriptional level affect gene expression of: is already being modified.
a. LDL-R o Post-transcriptional modification –
b. glucokinase modifications in the RNA after the transcription
c. PEPCK has been completed.
d. apoB48 & apo100 The DNA contains all the segments for the transcription of
Summarize the role of metformin in the regulation of key different proteins required by the cell and the RNA
processes in metabolism polymerase utilizes these parts of the gene in order for
transcription to commence.
I. OVERVIEW OF TRANSCRIPTION
Methylation
A. DEFINITION OF TERMS Adding of methyl groups to the DNA or RNA molecule
Central Dogma Different effects in methylation of DNA as compared to
Basic framework on how genetic information flows from a methylation of RNA
DNA sequence that stores information and determines the In RNA: Vital component in production of biologically active
sequence of RNA, which in turn determines the structure of t/r/mRNA
the protein. (Devlin) In DNA: Typically acts to repress gene expression
Trans Group 29 : Barbers, Belo, Buhat, Chan, de Guzman EDITOR: Andrea Cañete 1 of
6.02 20
TiTa
Gene Expression II: Transcription
BIOCHEMISTRY 4 of
20
TiTa
Gene Expression II: Transcription
BIOCHEMISTRY 5 of
20
TiTa
Gene Expression II: Transcription
D. STEPS IN INITIATION
1. TFIID binds to the TATA box promoter site via the TBP; binding
of TFIID distorts the sequence at the promoter region and this
serves as a landmark for other proteins
TBP is found in three different protein complexes,
depending on whether RNA Pol I,II, or III is involved
In the present case, TBP forms part of transcription factor
complex known as TFIID that is needed to recognize
promoters specific for RNA polymerase II
2. TFIIB is recruited to the promoter site by TFIID
3. TFIID then recruits TFIIA that stabilizes TFIID and TFIIB to the
promoter
Here, the Preinitiation Complex (PIC) is formed.
4. The PIC will recruit TFIIF and RNA Pol II with a clamp
downstream. TFIIF helps RNAP II target its promoters
5. Once RNA Pol II is in place the complex is in a state called RNA
Pausing
6. Finally, TFIIE binds and recruits TFIIH forming the Closed
Complex
7. TFIIH and TFIIJ are recruited together. Upon recruitment, the
protein complex is called the closed complex
8. TFIIH has a DNA helicase activity, which splits the DNA strands
from each other, giving RNA Pol II access to the anti-sense strand,
at this stage the complex I called an Open Complex
Recall the helicases separate the double-stranded DNA
into single strands allowing for the DNA template strand
to be transcribed Figure 13. RNA Pol II moves forward from the promoter.
9. TFIIH phosphorylates Carboxyl Terminal Domain (CTD) end Before RNA pol II can move forward, the binding of other factors must
of initiation and start of elongation occur. One of these, TFIIH, phosphorylates the tail of RNA polymerase II.
The tail changes position with respect to the body of RNA polymerase II.
The other factors leave and RNA polymerase moves along the DNA and
begins the process of transcription
BIOCHEMISTRY 6 of
20
TiTa
Gene Expression II: Transcription
E. ROLE OF CARBOXYL TERMINAL DOMAIN (CTD) IN Inactive: DBD is unavailable due to conformational
TRANSCRIPTION change
A ligand may activate or inactivate the transcription factor,
CTD – repetitive region at the C-terminus of RNA Pol II that may similarly the loss of a ligand may activate or inactivate a
be phosphorylated protein
Contains the following amino acid sequence repeated 50x: Mediator Protein
YSPTSPS (tyrosine-serine-proline-threonine-serine-proline- Scaffold for RNA Pol II
serine) Primary function: integrate all regulatory signals by activator
Phosphorylated not only during initiation, but also during the
or repressor proteins
whole processes of transcription
Upon activation, the RNA Pol is released from the mediator
protein and starts the process of elongation
III. ELONGATION
Phosphorylation of CTD
CTD is phosphorylated by TFIIH most commonly at 5th serine
residue
Phosphorylation of CTD releases RNA Pol II from the mediator
complex, allowing elongation to start
The phosphorylated CTD recruits:
Capping enzymes to prevent degradation of the mRNA at
the 5’-end
Methyl transferases, which assists in the reformation of the
histone complexes which are removed during unwinding of Figure 15. Elongation Process
the DNA by helicase activity
This recruitment allows from co-transcriptional modification of When RNAP is phosphorylated in the position of the promoter,
the mRNA elongation takes place.
Marks the termination of the initiation and start of Will commence only if the Carboxyl Terminal Domain (CTD)
Elongation, all the other GTFs have already dissociated is phosphorylated.
Facilitated by TFIIH
During elongation, a primary transcript is being formed in the
F. CLINICAL CORRELATION direction of 5’ to 3’
Xeroderma Pigmentosum During elongation, only TFIID remains with RNAP II while the
Due to the defective phosphorylation of the CTD because of rest of the TFs dissociates. (Other sources would indicate the
the mutation of TFIIH role of TFIIH is to phosphorylate TFIIH also remains with RNAP II
the CTD on the repeating amino acids Before RNA polymerase can move forward the binding of other
Characterized by severe photosensitivity. Brief exposure to factors must occur. TFIIH phosphorylates the tail of RNAP II.
sunlight would develop blisters, vesicular lesions on the skin The tail changes position with respect to the body of RNA
with burning sensation including appendages polymerase II. The other factors leave and RNA polymerase
Very prone to dehydration, very painful and high incidence of moves along the DNA and begins the process of transcription.
infection While elongation is taking place, modifications in the RNA
molecule is also taking place due to the co-transcriptional
modifications that are present in the process of transcription.
G. DNA BINDING DOMAIN AND MEDIATOR PROTEIN
Methylation of internal nucleotides can occur. Note that the
DNA Binding Domain (DBD) methylation of RNA segments is normal in producing a
Preset in Gene Specific Transcription Factors (GSTFs) normal, biologically active RNA molecule.
Sites in the GSTFs that allow them to bind into specific DNA
sequences
May be active or inactive depending on the conformation of
the transcription factors:
Active: DBD is available
BIOCHEMISTRY 7 of
20
TiTa
Gene Expression II: Transcription
Transcription Bubble
BIOCHEMISTRY 8 of
20
TiTa
Gene Expression II: Transcription
o Cap 1: first nucleotide of the transcript is methylated at signal (AAUAAA), a CA dinucleotide a few bases
C2’ downstream, and a GU-rich tract
o Cap 2: second nucleotide of the transcript that is 2) The polyadenylation complex consists of several proteins
methylated at C2’ that bind to these sequences, including poly(A) polymerase
itself, cleavage factor and poly(A)-binding protein (PABP)
3) The growing RNA is cut just beyond the CA site by cleavage
factor
There is cleavage between the CA and GU-rich
sequences. Therefore, GU-rich tract will be lost and
the CA dinucleotide will remain
After this cleavage, poly (A) polymerase attaches
adenine residues to the CA dinucleotide. This
would be the start of the synthesis of the poly-A tail
4) Poly(A) polymerase adds the poly(A) tail to the free 3’-end of
the mRNA. The completed poly(A) tail is bound by PABP
(Clark)
The rest of the polyadenylation complex would
Figure 18. Formation of the 5’-5’ phosphodiester bond between the 7- dissociate except for the PABP
methylguanosine cap and the first ribonucleotide in the RNA sequence
Figure 20. mRNA sequence showing the sequences beyond the end of
the coding sequence, which are involved in cutting and tail addition:
AAUAAA, CA dinucleotide, GU-rich
BIOCHEMISTRY 9 of
20
TiTa
Gene Expression II: Transcription
Splicing: Removal of introns
Primary transcript contains introns, which have to be The spliceosome consists of several ribonucleoproteins (U1
removed to U6), known as “snurps”, which are involved in splicing.
These assemble at the splice sites at the intron/exon
Introns: non-coding sequences; sequences that
boundaries (Clark).
are not represented in the final mRNA product (“int”
for intervening)
Exons are joined together, eliminating introns from the
primary transcript and forming a continuous sequence that
specifies a functional polypeptide.
Exons: coding sequences; sequences that are
retained to code for the protein products
Splicing involves the removal of the corresponding introns
and rejoining of the exons
Enzyme: Small nuclear ribonucleoproteins (snRNPs)
5’ end and 3’ end of exons are joined by the by the 5’ end of
the intron, forming an AGGU nucleotide sequence.
Spliceosomes are required to recognize the AGGU sequence
so that successful removal of the intron will occur.
Spliceosome/SNRNPS: responsible for splicing
Figure 23. The splicing reactions. Take note of the “lariat formation”
(like a loop) that occurs during splicing
BIOCHEMISTRY 10 of
20
TiTa
Gene Expression II: Transcription
Overview:
The genes for rRNA are located at multiple sites along the
DNA. A single transcribed unit of DNA yields an initial RNA
molecule of 45S. The 45S RNA is processed to yield the final
18S and 28S subunits of rRNA.
In eukaryotes, there are 4 rRNAs: the 5S rRNA is made
separately and does not need processing. The other three
(18S rRNA, 28S Rrna, and 5.8S rRNA) are made as a single
pre-rRNA.
BIOCHEMISTRY 11 of
20
TiTa
Gene Expression II: Transcription
BIOCHEMISTRY 12 of
20
TiTa
Gene Expression II: Transcription
The site on RRNA to be modified is identified by base pairing to
specific sequence on the snoRNA. After snoRNA/rRNA pairing,
the methylase binds to the BoxC and BoxD sequences and
then methylates one of the bases of the rRNA
Formation of snoRNA:
After splicing the mRNA, the intron assumes a lariat
structure; snoRNA is spliced from the intron, leaving
smaller fragments of RNA.
BIOCHEMISTRY 13 of
20
TiTa
Gene Expression II: Transcription
B. POST-TRANSCRIPTIONAL MODIFICATION
Timming
B. INITIATION
BIOCHEMISTRY 14 of
20
TiTa
Gene Expression II: Transcription
VIII. EXPORT TO CYTOPLASM
The formation of RNA in the nucleus should involve export to
the cytoplasm.
mRNA, tRNA, and rRNA function in the cytoplams. They move
out of the nucleus through the nuclear pore.
A. NUCLEAR PORE
Aminoacyl-tRNA synthetase
Figure 38. tRNA Synthesis. Important in translation, associated with export to the cytoplasm
The primary transcript is formed. Trimming and phosphorylation at the 5’ Catalyzes the activation of amino acids by linking them to their
and at the 3’ end occur. Attachment of CCA acceptor stem at 3’ end appropriate tRNA carriers so they can be incorporated into
happens next. Trimming and ligation of the introns on the anticodon loop proteins
then occur. The bases are then modified (Magat).
Ribonucleoprotein Particles (RNP Particles)
RNA polymerase III is the enzyme that produces tRNA. The
promoter is located within the coding region of the gene Has a role in the formation of P bodies
Primary transcripts for tRNA are cleaved at the 5’ and 3’ends Abnormal, easily degraded RNA can be screened by RNP
Some precursors contain introns that are removed particles. This occurs in the P bodies.
During processing of tRNA precursors, nucleotides are modified Form of mRNAs bound by specific packaging proteins for export
Post transcriptional modification includes the conversion of from the nucleus to the ribosomes for translation (protein
uridine to pseudouridine (Ψ), ribothymidine (T), and synthesis)
dihydrouridine (D)
Addition of the sequence CCA to the 3’ end is catalyzed by
nucleotidyl transferase
BIOCHEMISTRY 15 of
20
TiTa
Gene Expression II: Transcription
3. 5’ – 3’ exonuclease degrades the decapped RNA into
P Bodies nucleotides
Superkiller can digest 3’ to 5’ direction
Cytoplasmic organelles that are sites of translation repression
and mRNA decay Alternatively:
Formed by association of specific mRNAs with protein Polynucleotide phosphorylase degrades RNA via 3’ – 5’
constituents. exonuclease activity.
Some defective RNAs are processed here for degradation. It’s Inorganic phosphate is used to displace the phosphodiester
not only for export to the cytoplasm but also for further bondat the 3’-end of RNA, yielding a shorter RNA and a
screening. If the RNAs are defective, they will be degraded. nucleotide diphosphate
Histone Modification/Remodeling
Mainly involves unwinding of DNA around histones
Facilitated by:
SWI/SNF (switch sniff)
Can both slide and remodel nucleosome
ISWI (imitation switch)
Can only slide nucleosome and cannot rearrange them;
bind to histones rather than DNA
Sliding – slide nucleosomes along DNA molecule to expose the
transcription sequences
Figure 41. Acetylation and deacetylation of histones Exposes a previously inaccessible promoter
Remodeling – rearranging histones, remodeling nucleosomes
Note: into looser structure for easier DNA access; uses ATP as
In histone modification, the lysine residues in energy source
histones are acetylated, NOT THE DNA! Can merge 2 nucleosomes to loosen DNA winding, making
mRNA coding for histones do not have poly-A tail at more of the DNA accessible
their 3’ end
Use of Remodeling Complexes
Histone complexes 1 and 2 are affected
Promotes the release of DNA from the histones
Generating access to more promoter regions by the
transcription complex
BIOCHEMISTRY 17 of
20
TiTa
Gene Expression II: Transcription
LDL-Receptor Synthesis:
BIOCHEMISTRY 18 of
20
TiTa
Gene Expression II: Transcription
Certain molecules that undergo covalent modification,
specifically acetylation, enhances the LDL-R and cholesterol
synthesis
Glucokinase
Regulation via the presence of alternative promotion sites
Differential regulation of the glucokinase gene is accomplished
by using tissue specific promoters as it has different isoforms
Glucokinase (hexokinase 4) have different isoforms
The isoform depends on the exposed promoter region of the
gene to be transcribed
PEPCK/G6Pase Synthesis
Phosphoenol pyruvate carboxykinase (PEPCK) and Glucose-6-
phosphatase (G6Pase): for gluconeogenesis
Figure 47. Glucokinase promoter sites in differenct cell types Many GSTFs exist in the promoter region and the regulation
occurs via the presence of the different transcription factors
PEPCK is an “emergency enzyme” because it sustains normal
blood glucose levels in stressful states such as fasting
Critical component of normal brain function and survival
through fight or flight responses
Transcriptional control through mTORC2 – formerly mammalia
TORC2, now mechanistic TORC 2 – in T2DM patients with
uncontrolled hepatic gluconeogenesis
mTORC2 becomes very active in uncontrolled DM type 2
It will induce the translocation of cAMP in the nucleus
cAMP binds to CREB
This complex attaches itself to the promoter region,
attracting mTORC
mTORC attracts PGC1 α, inducing the successful
transcription and translation of mRNA producing PEPCK
and G6Pase
Leads to the uncontrolled mRNA production to produce
PEPCK/G6Pase
This would ultimately result to the uncontrolled hepatic
Figure 48. Glucokinase Regulation
gluceoneogenesis, which increases the glucose levels in the
blood
Apo B48 & B100
Regulation occurs via tissue specific RNA editing
Apo B48 – in the intestine = Chylomicrons
Intestinal mRNA altered by base editing to make Apo B48
Apo B100 – in the liver = VLDL
In the intestines, CAA sequence is targeted to become UAA
(stop codon)
A deaminase binds to the CAA region on the mRNA,
cytosine has an amino group on position 4, which will be
removed converting the cytosine nucleotide to uracil
This causes mRNA translation to terminate earlier in the
intestine
However in the liver, there is complete transcription which
results to the translation of Apo B100
Figure 50. Transcriptional Control of PEPCK synthesis
BIOCHEMISTRY 19 of
20
TiTa
Gene Expression II: Transcription
Metformin is a drug used to treat T2DM for more than 30 years c. Lys residue 4
An antihyperglycemic agent which improves glucose d. Both A and B
tolerance by lowering basal and postprandial blood glucose e. Both B and C
Decreases hepatic glucose production
Decreases intestinal absorption of glucose 4. The sigma σ subunit of prokaryotic RNA polymerase is
a. Part of the core enzyme
Improves insulin sensitivity by increasing peripheral glucose
b. Inhibited by antibiotic rifampicin
uptake/utilization
c. Must be present for transcription to occur
Although insulin secretion remains the same, fasting insulin
d. Specifically recognizes promoter sites.
levels and day long plasma insulin response may decrease
5. Which which ribonucleoprotein replaces U1 in the final
TORC2, under normal conditions, works with CREB, which is stage of spliceosome assembly?
activated by increased level of cAMP a. U2
Stimulate increased transcription of genes required for b. U3
gluconeogenesis c. U3AF
d. U6
Metformin stimulates the activation of AMPK, which
phosphorylates TORC2 and sequesters it in the cytoplasm. This Answers: 1FALSE (enhanced promoter access), 2FALSE (upstream) 3E, 4D, 5D
decreases the synthesis of gluconeogenic enzymes and
reducing hepatic output of glucose REFERENCES
Phosphorylation of TORC2 deactivates the enzyme
and this decrease gluconeogenesis 2020AC Trans
Action of metformin in decreasing glucose levels Lecturer’s PPT/Study Guide
MOA in Lipogenesis
Metformin inhibits SREBP1
Further inhibiting key enzymes in lipogenesis through
transcriptional control
HMG-R
FA synthase
Acetyl CoA carboxylase
Key enzymes controlled though phosphorylation:
HMG-R
Glycerol-3-phosphate acetyltransferase
Acetyl CoA carboxylase
Malonyl CoA decarboxylase
Only one activated while the former 3 are inhibited
Malonyl CoA decarboxylase enhances B-oxidation of FAs in
skeletal muscle. Instead of synthesis of lipids which happens
when SREBP1 is activated, degradation/B-oxidation takes
place.
Both covalent modification and transcriptional control on HMG-
R and Acetyl CoA carboxylase are exhibited by metformin
Metformin decreases FA and cholesterol synthesis, and
increases B-oxidation
REVIEW QUESTIONS
1. TRUE or FALSE: Disaggregation leads to diminished
promoter access.
BIOCHEMISTRY 20 of
20